Johnson & Johnson
JNJ
$154.64
Share price
0.23%
Change (1 day)
-2.42%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Market capitalization of Johnson & Johnson (JNJ)
Market cap: $372.16 Billion
As of May 2024 Johnson & Johnson has a market cap of $372.16 Billion. This makes Johnson & Johnson the world's 24th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Johnson & Johnson from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $372.16 B | -1.36% |
| 2023 | $377.31 B | -18.3% |
| 2022 | $461.84 B | 2.55% |
| 2021 | $450.35 B | 8.7% |
| 2020 | $414.30 B | 7.89% |
| 2019 | $384.00 B | 11.77% |
| 2018 | $343.57 B | -8.47% |
| 2017 | $375.36 B | 19.76% |
| 2016 | $313.43 B | 10.28% |
| 2015 | $284.22 B | -2.34% |
| 2014 | $291.04 B | 12.66% |
| 2013 | $258.34 B | 32.64% |
| 2012 | $194.77 B | 8.76% |
| 2011 | $179.08 B | 5.44% |
| 2010 | $169.85 B | -4.42% |
| 2009 | $177.71 B | 7.05% |
| 2008 | $166.00 B | -12.37% |
| 2007 | $189.44 B | -0.82% |
| 2006 | $191.01 B | 6.85% |
| 2005 | $178.76 B | -5.12% |
| 2004 | $188.42 B | 22.89% |
| 2003 | $153.32 B | -3.83% |
| 2002 | $159.42 B | -11.47% |
| 2001 | $180.09 B |
End of Day market cap according to different sources
On May 18th, 2024 the market cap of Johnson & Johnson was reported to be:
$372.16 Billion
$372.16 Billion
$372.16 Billion
$372.16 Billion
$371.30 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $209.58 B | -43.69% | 🇨🇭 Switzerland |
 Pfizer PFE | $162.29 B | -56.39% | 🇺🇸 USA |
 Abbott Laboratories ABT | $181.07 B | -51.35% | 🇺🇸 USA |
 Medtronic MDT | $114.08 B | -69.35% | 🇮🇪 Ireland |
 Eli Lilly LLY | $731.81 B | 96.63% | 🇺🇸 USA |
 Sanofi SNY | $122.00 B | -67.22% | 🇫🇷 France |
 Gilead Sciences GILD | $84.36 B | -77.33% | 🇺🇸 USA |
 Stryker Corporation SYK | $127.49 B | -65.74% | 🇺🇸 USA |
 Merck MRK | $332.27 B | -10.72% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $94.75 B | -74.54% | 🇬🇧 UK |